{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:02:38Z","timestamp":1788433358112,"version":"build-2803163510"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.3201\/eid3106.250076","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T15:19:24Z","timestamp":1748445564000},"source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of Nitroimidazole-Refractory Giardiasis Acquired in Different World Regions, Sweden, 2008\u20132020"],"prefix":"10.3201","volume":"31","author":[{"given":"Karin A.","family":"Ydsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Nederby","family":"\u00d6hd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Hellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmir","family":"Asgeirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3106.250076-202505161104-R1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QCO.0000000000000668","article-title":"Giardiasis treatment: an update with a focus on refractory disease.","volume":"33","author":"M\u00f8rch","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.3201\/eid3106.250076-202505161104-R2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.tmaid.2012.10.004","article-title":"Refractory giardiasis in Spanish travellers.","volume":"11","author":"Mu\u00f1oz Guti\u00e9rrez","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"key-10.3201\/eid3106.250076-202505161104-R3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3106.250076-202505161104-R4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/infdis\/jix066","article-title":"The use of quinacrine in nitroimidazole-resistant Giardia duodenalis: an old drug for an emerging problem.","volume":"215","author":"Requena-M\u00e9ndez","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3106.250076-202505161104-R5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/cid\/ciab513","article-title":"Efficacy and tolerability of quinacrine monotherapy and albendazole plus chloroquine combination therapy in nitroimidazole-refractory giardiasis: a TropNet study.","volume":"73","author":"Neumayr","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3106.250076-202505161104-R6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/infdis\/jiab287","article-title":"Quinacrine treatment of nitroimidazole-refractory giardiasis.","volume":"225","author":"Ydsten","year":"2022","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3106.250076-202505161104-R7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/0255-0857.142236","article-title":"Refractory giardiasis: a molecular appraisal from a tertiary care centre in India.","volume":"32","author":"Yadav","year":"2014","journal-title":"Indian J Med Microbiol"},{"key":"key-10.3201\/eid3106.250076-202505161104-R8","doi-asserted-by":"publisher","first-page":"1092.e1","DOI":"10.1016\/j.cmi.2019.12.017","article-title":"5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.","volume":"26","author":"Ca\u00f1ete","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3106.250076-202505161104-R9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1185\/03007995.2011.637915","article-title":"Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, clinical trial.","volume":"28","author":"Ca\u00f1ete","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"key-10.3201\/eid3106.250076-202505161104-R10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"key-10.3201\/eid3106.250076-202505161104-R11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/CMR.13.1.35","article-title":"Immune response to Giardia duodenalis.","volume":"13","author":"Faubert","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid3106.250076-202505161104-R12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/jac\/46.5.819","article-title":"Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.","volume":"46","author":"Lem\u00e9e","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3106.250076-202505161104-R13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0020-7519(94)00174-M","article-title":"In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay.","volume":"25","author":"Farbey","year":"1995","journal-title":"Int J Parasitol"},{"key":"key-10.3201\/eid3106.250076-202505161104-R14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1556\/1886.2021.00009","article-title":"Antimicrobial resistance of the enteric protozoon Giardia duodenalis - A narrative review.","volume":"11","author":"Loderst\u00e4dt","year":"2021","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"key-10.3201\/eid3106.250076-202505161104-R15","doi-asserted-by":"publisher","first-page":"taab120","DOI":"10.1093\/jtm\/taab120","article-title":"Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.","volume":"29","author":"Bourque","year":"2022","journal-title":"J Travel Med"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T15:19:24Z","timestamp":1748445564000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/6\/25-0076_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3106.250076","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}